(Q39407193)

English

Targeting EZH2 in cancer therapy

scientific article published on 29 June 2017

In more languages

default for all languages

No label defined

No description defined

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11 September 2017

1 reference

Europe PubMed Central

title

Targeting EZH2 in cancer therapy (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11 September 2017

Makoto Yamagishi

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

28665819

retrieved

11 September 2017

Kaoru Uchimaru

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

28665819

retrieved

11 September 2017

publication date

29 June 2017

1 reference

stated in

Europe PubMed Central

PubMed publication ID

28665819

retrieved

11 September 2017

published in

Current Opinion in Oncology

1 reference

stated in

Europe PubMed Central

PubMed publication ID

28665819

retrieved

11 September 2017

volume

29

1 reference

stated in

Europe PubMed Central

PubMed publication ID

28665819

retrieved

11 September 2017

issue

5

1 reference

stated in

Europe PubMed Central

PubMed publication ID

28665819

retrieved

11 September 2017

page(s)

375-381

1 reference

stated in

Europe PubMed Central

PubMed publication ID

28665819

retrieved

11 September 2017

cites work

Histone H2A deubiquitinase activity of the Polycomb repressive complex PR-DUB

1 reference

4 November 2023

https://opencitations.net/index/coci/api/v1/citations/10.1038/NATURE08966

Coordinated silencing of MYC-mediated miR-29 by HDAC3 and EZH2 as a therapeutic target of histone modification in aggressive B-Cell lymphomas

1 reference

30 December 2023

https://opencitations.net/index/api/v1/citations/10.1016/J.CCR.2012.09.003

Identifiers

DOI

10.1097/CCO.0000000000000390

1 reference

stated in

Europe PubMed Central

PubMed publication ID

28665819

retrieved

11 September 2017

PubMed publication ID

28665819

1 reference

stated in

Europe PubMed Central

PubMed publication ID

28665819

retrieved

11 September 2017

(Q39407193)

Targeting EZH2 in cancer therapy

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)